6j2o

Crystal structure of CTX-M-64 clavulanic acid complex

spinqualitylabelsall models 6j2o, resolution 1.90Å Show:Asymmetric Unit Biological Assembly Drag the structure with the mouse to rotate   Export Animated Image   Print3D Structural highlights 6j2o is a 2 chain structure with sequence from Escherichia coli. Full crystallographic information is available from OCA. For a guided tour on the structure components use FirstGlance. Method: X-ray diffraction, Resolution 1.9Å Ligands: ISS Resources: FirstGlance, OCA, PDBe, RCSB, PDBsum, ProSAT Function C8CP57_ECOLX Publication Abstract from PubMed The smart design of beta-lactamase inhibitors allowed us to combat extended-spectrum beta-lactamase (ESBL)-producing organisms for many years without developing resistance to these inhibitors. However, novel resistant variants have emerged recently, and notable examples are the CTX-M-190 and CTX-M-199 variants, which carried a S(130)T amino acid substitution and exhibited resistance to inhibitors such as sulbactam and tazobactam. Using mass spectrometric and crystallographic approaches, this study depicted the mechanisms of inhibitor resistance. Our data showed that CTX-M-64 (S(130)T) did not cause any conformational change or exert any effect on its ability to hydrolyze beta-lactam substrates. However, binding of sulbactam, but not clavulanic acid, to the active site of CTX-M-64 (S(130)T) led to the conformational changes in such active site, which comprised the key residues involved in substrate catalysis, namely, Thr(130), Lys(73), Lys(234), Asn(104), and Asn(132). This conformational change weakened the binding of the sulbactam trans-enamine intermediate (TSL) to the active site and rendered the formation of the inhibitor-enzyme complex, which features a covalent acrylic acid (AKR)-T(130) bond, inefficient, thereby resulting in inhibitor resistance in CTX-M-64 (S(130)T). Understanding the mechanisms of inhibitor resistance provided structural insight for the future development of new inhibitors against inhibitor-resistant beta-lactamases. Structural Insight into the Mechanism of Inhibitor Resistance in CTX-M-199, a CTX-M-64 Variant Carrying the S(130)T Substitution.,Cheng Q, Xu C, Chai J, Zhang R, Wai Chi Chan E, Chen S ACS Infect Dis. 2020 Apr 10;6(4):577-587. doi: 10.1021/acsinfecdis.9b00345. Epub , 2019 Nov 21. PMID:31709791 From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine. See Also Beta-lactamase 3D structures

Proteopedia Page Contributors and Editors (what is this?)

OCA